With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment. previousUS judge orders Trump administration to reopen Voice of AmericanextOil nears $110 a barrel after gas field strike
